Werewolf Therapeutics (HOWL) Announces Retirement of Chief Scientific Officer
Tweet
Share
E-mailGet Alerts HOWL Hot Sheet
Join SI Premium – FREE
On March 3, 2024, Cynthia Seidel-Dugan, Ph.D., notified Werewolf Therapeutics (NASDAQ: HOWL) of her intent to retire from her position as Chief Scientific Officer of the Company, effective as of March 29, 2024.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Werewolf Therapeutics to merge with Ambros in $150M private placement
- Lazard Global Total Return fund declares $0.1534 monthly distribution
Create E-mail Alert Related Categories
8K, Corporate News, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
